Guideline for investigation and management of adults and children presenting with a thrombocytosis

@article{Harrison2010GuidelineFI,
  title={Guideline for investigation and management of adults and children presenting with a thrombocytosis},
  author={Claire N. Harrison and David Bareford and Nauman M. Butt and Peter J. Campbell and Eibhlean Conneally and Mark W. Drummond and Wendy N Erber and Tamara Everington and Anthony R. Green and Georgina W. Hall and Beverley J. Hunt and Christopher A. Ludlam and Richard J A Murrin and Catherine Nelson-Piercy and Deepti H Radia and John T. Reilly and J. M. Van Der Walt and Bridget S. Wilkins and Mary Frances Frances McMullin},
  journal={British Journal of Haematology},
  year={2010},
  volume={149}
}
Guy’s and St Thomas’ NHS Foundation Trust, London, Russells Hall Hospital, Dudley, West Midlands, Arrowe Park Hospital Arrowe Park Road Upton Wirral, Wellcome Trust Sanger Institute, Hinxton, Cambridge, St. James Hospital, James Street, Dublin, Gartnavel General Hospital 21 Shelley Road Glasgow, Addenbrooke’s Hospital, Cambridge, Salisbury Healthcare NHS Trust, Salisbury, Wiltshire, Cambridge Institute for Medical Research, Hills Road, Cambridge, John Radcliffe Hospital, Headley Way, Headington… 
The use of genetic tests to diagnose and manage patients with myeloproliferative and myeloproliferative/myelodysplastic neoplasms, and related disorders
TLDR
This poster presents a probabilistic procedure to determine the carrier and removal status of Haematological Malignancy during the first trimester of pregnancy and traces the progression of disease through the first six weeks of gestation.
Patients with essential thrombocytosis during pregnancy: Challenges and therapeutic dilemmas
TLDR
Anticoagulation with low-molecular weight heparin is not generally recommended and should be considered during the last few weeks of pregnancy and postpartum and the addition of low dose aspirin seems to be beneficial in most cases improving pregnancy outcome.
Modification of British Committee for Standards in Haematology diagnostic criteria for essential thrombocythaemia
TLDR
The prevalence of mutations in exon 9 of the calreticulin gene have been described and it is suggested that these mutations are added to the British Committee for Standards in Haematology criteria for the diagnosis of ET and also PMF.
Experience of Myeloproliferative Neoplasms Guidelines in the United Kingdom: Perspective and International Context.
TLDR
The hematology community in the United Kingdom has an established process for identifying the need for a guideline and then producing and disseminating it, with particular reference to those for myeloproliferative neoplasms (MPNs).
Guideline for the diagnosis and management of myelofibrosis
TLDR
The objective of this guideline is to provide healthcare professionals with clear guidance on the investigation and management of primary myelofibrosis, as well as post‐polycythaemic myel ofibrosis (post‐PV MF) and post‐thrombocythemic myelo‐oncology ( post‐ET MF) in both adult and paediatric patients.
Essential thrombocythaemia treated with recombinant interferon: ‘real world' United Kingdom referral centre experience
TLDR
A large, well‐annotated cohort of ET patients from a single referral centre undergoing therapy with either IFNα or (PEG)‐IFN‐α‐2a/2b demonstrate high rates of complete haematological responses, good tolerability and safety, low rates of thromboembolic events in compliant patients and confirm feasibility of long‐term therapy in a significant proportion of patients.
Clinical and laboratory assessment of a patient with thrombocytosis.
TLDR
A logical approach is provided to distinguishing reactive or secondary thrombocytosis from thrommosis associated with an underlying myeloproliferative neoplasm and an overview of the management of essential throm bocythaemia is given.
Aspirin in low-risk essential thrombocythemia, not so simple after all?
Thrombocytosis and infections in childhood.
TLDR
In both children and adults, thrombocytosis is usually defined as a platelet count of more than 450 10/ L, and infections are the main cause of pediatric RT, with reported incidence rates ranging from 37% to 78%.
MPL Baltimore Mutation and Thrombocytosis: Case Report and Literature Review
TLDR
An 11-month-old Ethiopian Jewish boy referred for evaluation of thrombocytosis who was found to be homozygous for MPL Baltimore is described, and this entity should be considered in the differential diagnosis of every patient with thromBocyTosis, particularly those of African origin.
...
...

References

SHOWING 1-10 OF 167 REFERENCES
Guidelines on the investigation and management of antiphospholipid syndrome
This guidance updates and replaces the previous guideline on the investigation and management of antiphospholipid syndrome (APS) published in 2000 (Greaves et al, 2000), though where there have not
Reye's syndrome and aspirin.
TLDR
There can now be no reasonable doubt that aspirin given to a child infected with chickenpox or influenza increases his or her risk of developing Reye's syndrome, and paediatric prescriptions for aspirin should be more careful.
Incidence, clinical features and outcome of essential thrombocythaemia in a well defined geographical area
TLDR
This study provides population‐based data suggesting the benefit of treatment with low‐dose ASA in a non‐selected population of patients with ET.
The management of ‘low‐risk’ and ‘intermediate‐risk’ patients with primary thrombocythaemia
TLDR
It was concluded that the thrombotic risk in young PT patients, with no thromBotic history and a platelet count <1500 ́ 10/l, was not increased compared to the normal population and that a conservative therapeutic approach should therefore be considered in these patients.
The management of ‘low‐risk’ and ‘intermediate‐risk’ patients with primary thrombocythaemia
TLDR
It was concluded that the thrombotic risk in young PT patients, with no thromBotic history and a platelet count <1500 ́ 10/l, was not increased compared to the normal population and that a conservative therapeutic approach should therefore be considered in these patients.
Investigation and management of heritable thrombophilia
TLDR
With the developing interest in the role of prothrombotic abnormalities in thrombosis risk, haematologists and other clinicians have come under pressure to initiate laboratory tests on an increasing number of patients and there are several important issues relevant to the clinical utility and cost effectiveness.
Guidelines On The Investigation and Management Of The Antiphospholipid Syndrome
TLDR
These revised guidelines on testing for the lupus anticoagulant have been prepared against this background and cover both clinical and laboratory aspects.
Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment.
TLDR
It is rational to suggest that lower doses of aspirin might be associated with less hemorrhage and, perhaps, a beneficial effect on thrombosis and the role of antithrombotic agents such as aspirin in ET remains to be shown.
The incidence of thrombotic and hemorrhagic disorders in association with extreme thrombocytosis: An analysis of 129 cases
TLDR
A retrospective study of 129 patients with platelet counts of 1,000 × 109/L or more with myeloproliferative disorders and reactive thrombocytosis to determine the incidence of thrombohemorrhagic complications finds that bleeding was generally not severe, with only six patients requiring transfusions.
...
...